Gentizol Otic Ointment for Dogs - 15g Tube

VetOne Gentizol Ointment is indicated for the treatment of canine acute and chronic otitis externa associated with yeast Malassezia pachydermatis (formerly Pityrosporum canis) and/or bacteria susceptible to gentamicin. For otic use in dogs only.

DOSAGE AND ADMINISTRATION: 
The external ear should be thoroughly cleaned and dried before treatment. 
Remove foreign material, debris, crusted exudates, etc., with suitable non-irritating solutions. Excessive hair should be clipped from the treatment area. 
After verifying that the eardrum is intact, instill 4 drops 2 drops from the 215 g. bottle of Gentizol ointment twice daily into the ear canal of dogs weighing less than 30 lbs. 
Instill 8 drops 4 drops from the 215 g. bottle twice daily into the ear canal of dogs weighing 30 lbs. or more. 
Therapy should continue for 7 consecutive days.

INGREDIENTS:
Each gram contains gentamicin sulfate, USP equivalent to 3 mg gentamicin base betamethasone valerate, USP equivalent to 1 mg betamethasone and 10 mg clotrimazole, USP in a mineral oil & ndashbased system containing a plasticized hydrocarbon gel.

CONTRAINDICATIONS: 
If hypersensitivity to any of the components occurs, treatment should be discontinued and appropriate therapy instituted. Concomitant use of drugs known to induce ototoxicity should be avoided. Do not use in dogs with known perforation of eardrums.

WARNINGS: 
The use of gentamicin-betamethasone-clotrimazole ointment has been associated with deafness or partial hearing loss in a small number of sensitive dogs e.g., geriatric. The hearing deficit is usually temporary. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue use of gentamicin-betamethasone-clotrimazole ointment immediately and flush the ear canal thoroughly with a non-ototoxic solution. Corticosteroids administered to dogs, rabbits, and rodents during pregnancy have resulted in cleft palate in offspring. Other congenital anomalies including deformed forelegs, phocomelia, and anasarca have been reported in offspring of dogs which received corticosteroids during pregnancy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis.